WEATHER ALERT
Biden boosts US vaccine stockpile as world waits
Read full article: Biden boosts US vaccine stockpile as world waitsWhite House aides said Biden’s first priority is ensuring that Americans are vaccinated before considering distributing doses elsewhere. AdRussia has sent millions of doses of its Sputnik V vaccine to countries around the world, even as it vaccinates its own population. Israel, which has vaccinated more than half of its population with Pfizer vaccines produced in Europe, has also attempted to use vaccine diplomacy to reward allies. Biden's purchasing strategy has come under criticism from nongovernmental organizations who have encouraged the White House to develop clear plans and thresholds for sharing vaccine with the world. So we’re not going to be ultimately safe until the world is safe,” acknowledged Biden.
Biden boosts US vaccine stockpile as world waits
Read full article: Biden boosts US vaccine stockpile as world waitsWhite House aides said Biden’s first priority is ensuring that Americans are vaccinated before considering distributing doses elsewhere. AdRussia has sent millions of doses of its Sputnik V vaccine to countries around the world, even as it vaccinates its own population. Israel, which has vaccinated more than half of its population with Pfizer vaccines produced in Europe, has also attempted to use vaccine diplomacy to reward allies. Biden's purchasing strategy has come under criticism from nongovernmental organizations who have encouraged the White House to develop clear plans and thresholds for sharing vaccine with the world. So we’re not going to be ultimately safe until the world is safe,” acknowledged Biden.
Biden immediately begins selling virus aid plan to public
Read full article: Biden immediately begins selling virus aid plan to publicBiden will sign the bill into law on Friday, but the White House didn’t wait, turning the bill signing into a three-day event. Biden on Wednesday announced that his administration is aiming to secure an additional 100 million doses of the single-shot vaccine developed by Johnson & Johnson. He appeared at an event with executives from Johnson & Johnson and Merck, rival companies both producing doses of the new vaccine. The Obama White House secured its passage, but then the Democratic Party took a big hit in the midterm elections. “You’ve got to create an echo chamber and amplify it,” said Adrienne Elrod, a Democratic strategist close to the White House.
J&J 4Q sales rise despite pandemic, but charges cut profits
Read full article: J&J 4Q sales rise despite pandemic, but charges cut profitsJohnson & Johnson reported a strong finish to the year, overcoming the disruption of the global pandemic on some parts of its business like medical devices. Meanwhile, Johnson & Johnson also is testing a two-dose vaccine as a backup and should have results on that in 2021's second half. The pandemic, and the associated deferral of many medical procedures, reduced sales of surgery, vision care and orthopedics products. Prescription drug sales jumped 16.3%, to $12.27 billion, led by immune disorder drug Stelara and cancer drugs Darzelex, Imbruvica and Erleada. For all of 2020, Johnson & Johnson reported revenue of $82.58 billion, up just 0.6% from 2019, and net income of $14.71 billion, which was 2.7% below 2019's net income.
The Latest: 2 Philippine tourist spots partially reopen
Read full article: The Latest: 2 Philippine tourist spots partially reopenA separate data system operated by state health officials has documented around 2,300 infections among school-age children since Sept. 1. ___MILAN — Italy has tallied 2,548 new coronavirus cases, the highest daily total in five months. — Maryland is reporting zero coronavirus deaths in a 24-hour period for the first time since March 28. That doesn’t necessarily mean no COVID-19 deaths occurred in that time frame, because sometimes there is a delay in the submission of a death certificate. ___LONDON — The European Medicines Agency has begun its first review process for an experimental COVID-19 vaccine being developed by Oxford University and AstraZeneca.